Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

Scopus Author ID: 56865714800
Loop profile: 837607

Activities

Collapse all

Works (20)

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline

Journal of Clinical Oncology
2023-04-01 | Journal article
DOI: 10.1200/JCO.22.02462
Contributors: Praveen Vikas; Hans Messersmith; Carolyn Compton; Lynette Sholl; Russell R. Broaddus; Anjee Davis; Maria Estevez-Diz; Rohan Garje; Panagiotis A. Konstantinopoulos; Aliza Leiser et al.
Source: check_circle
Crossref

Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

JCO Oncology Practice
2022-09 | Journal article
DOI: 10.1200/OP.22.00284
Contributors: Praveen Vikas; Larissa A. Korde; Mark R. Somerfield; Dawn L. Hershman
Source: check_circle
Crossref

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.

JMIR cancer
2022-05-19 | Journal article
DOI: 10.2196/33859
PMID: 35588361
Source: Self-asserted source
PRAVEEN VIKAS

Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer

Cancers
2021-12-31 | Journal article
DOI: 10.3390/cancers14010206
Contributors: Chandra K. Maharjan; Jiao Mo; Lei Wang; Myung-Chul Kim; Sameul Wang; Nicholas Borcherding; Praveen Vikas; Weizhou Zhang
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2021-11-01 | Journal article
DOI: 10.1200/jco.21.01992
PMID: 34724386
Source: Self-asserted source
PRAVEEN VIKAS

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2021-11-01 | Journal article
DOI: 10.1200/jco.21.01440
PMID: 34724392
Source: Self-asserted source
PRAVEEN VIKAS

<p>Repurposing Anti-Cancer Drugs for COVID-19 Treatment</p>

Drug Design, Development and Therapy
2020-11 | Journal article
DOI: 10.2147/DDDT.S282252
Contributors: Nicholas Borcherding; Yogesh Jethava; Praveen Vikas
Source: check_circle
Crossref

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.

Cancer cell
2020-10-29 | Journal article
DOI: 10.1016/j.ccell.2020.10.022
PMID: 33176160
PMC: PMC7598547
Source: Self-asserted source
PRAVEEN VIKAS

Treatment of Stage IV Colon Cancer in the United States: A Patterns-of-Care Analysis.

Journal of the National Comprehensive Cancer Network : JNCCN
2020-06-01 | Journal article
DOI: 10.6004/jnccn.2020.7533
PMID: 32502984
Source: Self-asserted source
PRAVEEN VIKAS

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Lancet (London, England)
2020-05-28 | Journal article
DOI: 10.1016/s0140-6736(20)31187-9
PMID: 32473681
PMC: PMC7255743
Source: Self-asserted source
PRAVEEN VIKAS

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors.

Frontiers in oncology
2020-04-28 | Journal article
DOI: 10.3389/fonc.2020.00570
PMID: 32457830
PMC: PMC7228136
Source: Self-asserted source
PRAVEEN VIKAS

<p>t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma</p>

OncoTargets and Therapy
2019-07 | Journal article
DOI: 10.2147/OTT.S208290
Contributors: Kalyan Nadiminti; Margarida Silverman; Sharathkumar Bhagavathi; Praveen Vikas
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2019-06-17 | Journal article
DOI: 10.1200/jco.19.00948
PMID: 31206315
Source: Self-asserted source
PRAVEEN VIKAS

Engaging Stakeholders in the Development of an eHealth Intervention for Cancer Symptom Management for Rural Residents

Journal of Rural Health
2018 | Journal article
DOI: 10.1111/jrh.12297
EID:

2-s2.0-85045915566
Contributors: Gilbertson-White, S.; Yeung, C.W.; Saeidzadeh, S.; Tykol, H.; Vikas, P.; Cannon, A.
Source: Self-asserted source
PRAVEEN VIKAS via Scopus - Elsevier

Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer

Journal of Molecular Biology
2018 | Journal article
DOI: 10.1016/j.jmb.2018.05.030
EID:

2-s2.0-85047641994
Contributors: Borcherding, N.; Kolb, R.; Gullicksrud, J.; Vikas, P.; Zhu, Y.; Zhang, W.
Source: Self-asserted source
PRAVEEN VIKAS via Scopus - Elsevier

The clinical promise of immunotherapy in triple-negative breast cancer

Cancer Management and Research
2018 | Journal article
DOI: 10.2147/CMAR.S185176
EID:

2-s2.0-85058979112
Contributors: Vikas, P.; Borcherding, N.; Zhang, W.
Source: Self-asserted source
PRAVEEN VIKAS via Scopus - Elsevier

Palliative and supportive interventions to improve patient-reported outcomes in rural residents with cancer

Journal of Community and Supportive Oncology
2017 | Journal article
DOI: 10.12788/jcso.0348
EID:

2-s2.0-85039754058
Contributors: Gilbertson-White, S.; Saeidzadeh, S.; Yeung, C.W.; Tykol, H.; Vikas, P.
Source: Self-asserted source
PRAVEEN VIKAS via Scopus - Elsevier

Challenges of rural cancer care in the United States

ONCOLOGY (United States)
2015 | Journal article
EID:

2-s2.0-84942134686
Contributors: Charlton, M.; Schlichting, J.; Chioreso, C.; Ward, M.; Vikas, P.
Source: Self-asserted source
PRAVEEN VIKAS via Scopus - Elsevier

Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update

Expert Review of Hematology
2013 | Journal article
DOI: 10.1586/17474086.2014.857596
Part of ISSN: 1747-4086
Contributors: Bei Hu; Praveen Vikas; Mohamad Mohty; Bipin N Savani
Source: Self-asserted source
PRAVEEN VIKAS via Crossref Metadata Search
grade
Preferred source (of 2)‎

Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease

Bone Marrow Transplantation
2011-11 | Journal article
DOI: 10.1038/bmt.2011.226
Part of ISSN: 0268-3369
Contributors: D Dunn; P Vikas; M Jagasia; B N Savani
Source: Self-asserted source
PRAVEEN VIKAS via Crossref Metadata Search
grade
Preferred source (of 2)‎

Peer review (6 reviews for 2 publications/grants)

Review activity for Breast cancer research and treatment. (3)
Review activity for Journal for immunotherapy of cancer. (3)
How many people are using ORCID?